Summary
Updated Aug 30, 2026
Hans T. Schambye is Chief Executive Officer of Damora Therapeutics, Inc. (DMRA). 3 SEC Form 4 filings on record going back to 2024, most recently on 6 January 2026. Most recent open-market trade: sold $15K of DMRA on 6 January 2026. Lifetime open-market sales: $17K.
Recent Transactions
4Every recent SEC Form 4 transaction Hans T. Schambye has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Hans T. Schambye files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Garrett Winslow - $13K of DMRA open-market activity in the last 12 months
- Lori Firmani - $3K of DMRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Hans T. Schambye?
Hans T. Schambye is a corporate insider, tracked as Chief Executive Officer of Damora Therapeutics, Inc. (DMRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Hans T. Schambye last file a Form 4?
The most recent primary Form 4 on record is dated 6 January 2026, one of 3 filings going back to 2024.
Has Hans T. Schambye been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($17K) across all tracked filings.
Where can I see all of Hans T. Schambye's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Hans T. Schambye and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
